In the past week, RGEN stock has gone up by 11.36%, with a monthly decline of -3.36% and a quarterly surge of 30.10%. The volatility ratio for the week is 3.52%, and the volatility levels for the last 30 days are 3.94% for Repligen Corp The simple moving average for the past 20 days is 2.08% for RGEN’s stock, with a 10.41% simple moving average for the past 200 days.
Is It Worth Investing in Repligen Corp (NASDAQ: RGEN) Right Now?
Company’s 36-month beta value is 0.94.Analysts have differing opinions on the stock, with 10 analysts rating it as a “buy,” 4 as “overweight,” 6 as “hold,” and 0 as “sell.”
The public float for RGEN is 52.90M, and currently, short sellers hold a 6.25% ratio of that floaft. The average trading volume of RGEN on February 20, 2025 was 533.23K shares.
RGEN) stock’s latest price update
Repligen Corp (NASDAQ: RGEN)’s stock price has soared by 7.66 in relation to previous closing price of 150.73. Nevertheless, the company has seen a gain of 11.36% in its stock price over the last five trading days. zacks.com reported 2025-02-20 that Repligen (RGEN) came out with quarterly earnings of $0.44 per share, beating the Zacks Consensus Estimate of $0.41 per share. This compares to earnings of $0.33 per share a year ago.
Analysts’ Opinion of RGEN
Many brokerage firms have already submitted their reports for RGEN stocks, with TD Cowen repeating the rating for RGEN by listing it as a “Buy.” The predicted price for RGEN in the upcoming period, according to TD Cowen is $200 based on the research report published on February 10, 2025 of the current year 2025.
Canaccord Genuity, on the other hand, stated in their research note that they expect to see RGEN reach a price target of $165. The rating they have provided for RGEN stocks is “Hold” according to the report published on December 17th, 2024.
RGEN Trading at 4.39% from the 50-Day Moving Average
After a stumble in the market that brought RGEN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -21.93% of loss for the given period.
Volatility was left at 3.94%, however, over the last 30 days, the volatility rate increased by 3.52%, as shares sank -2.76% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +14.04% upper at present.
During the last 5 trading sessions, RGEN rose by +11.33%, which changed the moving average for the period of 200-days by -2.45% in comparison to the 20-day moving average, which settled at $158.96. In addition, Repligen Corp saw 12.74% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at RGEN starting from Hunt Anthony, who sale 24,246 shares at the price of $139.67 back on Nov 21 ’24. After this action, Hunt Anthony now owns 139,840 shares of Repligen Corp, valued at $3,386,439 using the latest closing price.
Anthony Hunt, the Executive Chairman of Repligen Corp, proposed sale 24,246 shares at $139.66 during a trade that took place back on Nov 21 ’24, which means that Anthony Hunt is holding shares at $3,386,311 based on the most recent closing price.
Stock Fundamentals for RGEN
Current profitability levels for the company are sitting at:
- -0.01 for the present operating margin
- 0.47 for the gross margin
The net margin for Repligen Corp stands at -0.03. The total capital return value is set at -0.0. Equity return is now at value -0.41, with -0.30 for asset returns.
Based on Repligen Corp (RGEN), the company’s capital structure generated 0.25 points at debt to capital in total, while cash flow to debt ratio is standing at 0.25. The debt to equity ratio resting at 0.33. The interest coverage ratio of the stock is -0.29.
Currently, EBITDA for the company is 127.77 million with net debt to EBITDA at -1.28. When we switch over and look at the enterprise to sales, we see a ratio of 14.56. The receivables turnover for the company is 4.77for trailing twelve months and the total asset turnover is 0.22. The liquidity ratio also appears to be rather interesting for investors as it stands at 10.44.
Conclusion
In a nutshell, Repligen Corp (RGEN) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
